Australia's most trusted
source of pharma news
Posted 19 November 2025 AM
Despite shake-ups in the pharmaceutical industry, more than half of the top 20 companies by market capitalisation reported growth in their total worth over the third quarter of this year, with one surging enough to break into the Top 20 list.
Overall, the combined market cap of 20 largest pharmas increased four per cent quarter on quarter, from US$3.7 trillion on 30 June 2025 to US$3.8 trillion on 30 September 2025. It still leaves it a bit lower than the US$3.92 trillion it was at the end of the first quarter.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.